A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells
Authors:
- Baoan ChenBCBaoan Chen
- Shukui QinSQShukui Qin
- Suyi LiSLSuyi Li
- Xiangming HeXHXiangming He
- Shaomin QiuSQShaomin Qiu
- Wei ZhaoWZWei Zhao
- Hong ZhaoHZHong Zhao
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 392 (2) , 190-195
Abstract
No abstract availableKeywords
Funding Information
- Nanjing Committee of Science and Technology (ZKX 07005)
This publication has 33 references indexed in Scilit:
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular FunctionsScience, 2009
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cellsin vitroandin vivowith particular efficacy for small cell lung cancerMolecular Cancer Therapeutics, 2009
- New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancerJournal of Hematology & Oncology, 2009
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Histone deacetylase inhibitors in cancer therapyCurrent Opinion in Oncology, 2008
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapyCancer Letters, 2008
- Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase SignalingMolecular Pharmacology, 2007
- The role of histone deacetylases (HDACs) in human cancerMolecular Oncology, 2007
- Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma CellsOncology, 2004
- Annexin V used for measuring apoptosis in the early events of cellular cytotoxicityCytometry, 1999